(Q44872781)

English

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity

scientific article published on 30 October 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

phosphorylation

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Starczynowski DT

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Trautmann H

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Pott C

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Harder L

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Africa JA

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Leeman JR

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Siebert R

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Gilmore TD

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

30 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2685-2694

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Jesterone dimer, a synthetic derivative of the fungal metabolite jesterone, blocks activation of transcription factor nuclear factor kappaB by inhibiting the inhibitor of kappaB kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Mining for regulatory programs in the cancer transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

IkappaB kinase complexes: gateways to NF-kappaB activation and transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Tumor Necrosis Factor-α Activation of NF-κB Requires the Phosphorylation of Ser-471 in the Transactivation Domain of c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional genomic analysis reveals distinct neoplastic phenotypes associated with c-myb mutation in the bursa of Fabricius

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210089

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44872781&oldid=2206968861"